If you have spent any time in the weight loss coaching space — the Instagram coaches, the “mindset” coaches, the certified nutritionists, the various flavors of structured wellness practitioner — you have probably noticed something specific about the way they talk about GLP-1 medications.
They mostly don’t.
They will talk endlessly about protein. They will talk about cortisol. They will talk about hormone-balancing breakfasts and seed cycling and lymphatic drainage and walking meditation. They will rarely talk about Ozempic. When they do, it is almost always to caution against it, to position their own work as “the natural alternative,” or to gently suggest that their philosophy doesn’t really overlap with that medical decision.
And here is the more revealing part: if you reach out to most established coaches and disclose that you are on a GLP-1 or have recently come off one, you will often be told politely that you might not be the right fit for their program. Sometimes the language is more direct — “I don’t take medicated clients.” Sometimes it’s softer — “my approach is designed for women working with food, not pharmacology.”
This avoidance is consistent enough across the industry to be a structural feature, not a personal preference. The question is why.
The first reason: it threatens their model
The dominant coaching model in the women’s weight loss space has been built, for the last decade, around the premise that weight is a behavioral and emotional problem. The coach’s value proposition is to help the client identify the behavioral, emotional, and psychological drivers of their relationship with food, and to install new patterns that produce a different outcome.
This model has been substantially profitable. It has also been substantially correct for a meaningful subset of women.
GLP-1 medications threaten this model not because they don’t work — they obviously work — but because they produce dramatic weight loss without requiring much of what the coaching model is designed to deliver. A woman who has lost 50 pounds on tirzepatide while continuing to eat the same foods at roughly the same times has, in some empirical sense, achieved the outcome the coaching industry promised through different means. Many coaches have responded to this threat by classifying the result as somehow less valid, less sustainable, or less “real.”
This is a marketing position, not a clinical position.
The second reason: it’s outside their training
This one is more sympathetic.
Most coaches in the women’s weight loss space are not trained as clinicians. They are certified through programs that teach behavioral change frameworks, motivational interviewing, basic nutrition, and various flavors of wellness philosophy. These are useful skills. They are not, however, training in pharmacology, in the specifics of how GLP-1 receptor agonists modulate hypothalamic signaling, or in how to interpret the metabolic state of a woman who has just discontinued a drug that was doing some of her pancreatic and gastric work for her for the past year.
An honest coach who looks at a post-GLP-1 client and recognizes that the situation requires knowledge they don’t have, who declines to take that client, is doing a more responsible thing than a coach who takes the client and applies the standard framework anyway.
The problem is not that responsible coaches are declining. The problem is that the population of women who need a coach with the right training has, until very recently, had nowhere to go.
The third reason: liability
The third reason most coaches won’t touch GLP-1 clients is the one that is rarely said out loud.
Coaching is an unregulated industry in most jurisdictions. Coaches are not licensed practitioners. They cannot prescribe, diagnose, or treat medical conditions. They operate in a legal space that allows them to offer behavioral support but explicitly does not allow them to function as adjuncts to medical care.
The moment a coach takes on a client who is on or recently off a prescription medication, the coach’s liability exposure changes. If the client experiences an adverse event — a hypoglycemic episode, a gallbladder issue, a thyroid concern, any of the various conditions that GLP-1 use has been associated with — and the coach has been involved in shaping the client’s nutritional protocol, the legal question becomes whether the coach’s involvement contributed.
Most coaches do not carry malpractice-equivalent insurance. Most coaches’ legal disclaimers, while strongly worded, would not necessarily insulate them in a scenario where a court found that they had effectively been practicing medicine. The rational response to this exposure is to decline the client category that produces it.
This is not cynical. It is a real structural reason why the women who most need a structured maintenance protocol have been the women least able to find one.
The population of women who need a coach with the right training has, until very recently, had nowhere to go.
The fourth reason: the wellness brand voice doesn’t fit
This is the soft reason underneath the other three.
The dominant brand voice in the women’s wellness coaching space is built around a particular emotional register: warmth, encouragement, embodiment, intuition, gentleness, self-trust, “listening to your body.” This vocabulary has been effective at marketing to a particular slice of the market. It is fundamentally incompatible with the actual situation of a post-GLP-1 client.
The post-GLP-1 client’s body is not, in the relevant sense, available to be listened to right now. Her hunger system is in upregulated rebound. Her satiety signals are degraded. Her intuition about food was, by her own report, the reason she sought pharmacological intervention in the first place. “Listening to your body” is not a viable strategy in this window — in fact, it is precisely the strategy that the standard model would suggest, and it is precisely the strategy that doesn’t work here.
A coach whose entire brand identity is built around “intuitive” approaches doesn’t have a clean way to take on a client for whom intuition is the wrong tool. The coach either has to take the client and use methods that contradict her brand, or decline the client and protect the brand. Most decline.
What this means for the industry
The result of these four factors is that several million women in the US alone — the estimated population currently on or recently off a GLP-1 medication — have been served by an industry that is, in aggregate, ill-equipped to support them through their most consequential phase.
This is what we mean when we talk about “the gap.” The gap is not that no support exists. The gap is that the support that exists was built for a different patient and is delivered in a voice that doesn’t translate.
The gap is also why a wave of new programs — WeWontRegain among them — have appeared in the last 18 months, all attempting some version of the same insight: that this population needs a different model, a different vocabulary, a different evidence base, and a different relationship to medical care than the existing coaching industry was built to provide.
We’re not most coaches. Talk to one of ours for free, for fifteen minutes →
What a coach for this work has to actually be
If you are evaluating a post-GLP-1 coaching program, the following are the questions worth asking. Most of the standard wellness industry will not have good answers to these:
- ✓ Does your clinical team include a registered dietitian licensed in your state?
- ✓ Are your coaches trained specifically in post-GLP-1 metabolic care, or in general weight loss?
- ✓ Does the program coordinate with my prescribing physician, or operate independently of medical care?
- ✓ What is your protocol for the ghrelin rebound window specifically?
- ✓ What does the program look like at month 12, when most women are at peak regain risk?
- ✓ Are your coaches still working with clients at the 18-month mark, or does the program end before that window closes?
A program that cannot answer these questions clearly is operating in the same space as the coaches who decline GLP-1 clients — they just haven’t admitted to themselves that they should be declining.
Why we built this
WeWontRegain exists because the structural reasons most coaches decline this work are real, and they don’t fix themselves through good intentions. The fix is to build an organization with the actual clinical credentials, the actual training, the actual liability framework, and the actual brand voice the population requires.
Every member of our clinical team is a credentialed practitioner — registered dietitians, certified menopause practitioners, or exercise physiologists with specific training in post-pharmacological metabolic care. Every member of our program receives a protocol calibrated for the specific window she is in. Every conversation we have is built on the assumption that her decision to use a GLP-1 was a reasonable decision, made with her doctor, and that our job is to support the outcome of that decision — not to relitigate it.
That is, structurally, the difference. Not a different vibe. A different model.
If the questions in this article apply to your search, the 15-minute consult is where you stress-test our answers. Book yours free →